Literature DB >> 27784747

Mechanisms through Which Hypoxia-Induced Caveolin-1 Drives Tumorigenesis and Metastasis in Hepatocellular Carcinoma.

Xiaowen Mao1, Sivia Yuen Sze Wong1, Edith Yuk Ting Tse1, Frankie Chi Fat Ko1, Sze Keong Tey1, Yin Shan Yeung1, Kwan Man2, Regina Cheuk-Lam Lo1,3, Irene Oi-Lin Ng1,3,4, Judy Wai Ping Yam5,3,4.   

Abstract

In solid tumors, hypoxia triggers an aberrant vasculogenesis, enhances malignant character, and elevates metastatic risk. The plasma membrane organizing protein caveolin-1 (Cav1) is increased in a variety of cancers, including hepatocellular carcinoma (HCC), where it contributes to metastatic capability. However, the reason for elevation of Cav1 in tumor cells and the mechanistic basis for its contributions to metastatic risk are not fully understood. Here, we show that in HCC cells, hypoxia elevates expression of Cav1, which then acts through the calcium-binding protein S100P to promote metastasis. Hypoxic regions of HCC xenografts displayed elevated expression of Cav1. Hypoxia promoted HCC cell migration and invasion and distant pulmonary metastases, whereas Cav1 silencing abolished these effects. Gene expression profiling revealed that hypoxia-induced Cav1 functioned as a positive regulator of S100P via activation of the NF-κB pathway. S100P elevation under hypoxic conditions was abrogated by silencing of Cav1 or NF-κB function. Conversely, restoring S100P in Cav1-silenced cells rescued the migratory potential of HCC cells along with tumor formation and lung metastasis. In clinical specimens of HCC, we observed S100P overexpression to correlate with venous invasion, microsatellites, direct liver invasion, and absence of tumor encapsulation. Collectively, our findings demonstrated how hypoxia-induced expression of Cav1 in HCC cells enhances their invasive and metastatic potential. Cancer Res; 76(24); 7242-53. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27784747     DOI: 10.1158/0008-5472.CAN-16-1031

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

1.  Pterostilbene Nanoparticles Downregulate Hypoxia-Inducible Factors in Hepatoma Cells Under Hypoxic Conditions.

Authors:  Wen-Sheng Tzeng; Wei-Lin Teng; Pao-Hsien Huang; Tzu-Ching Lin; Feng-Lin Yen; Yow-Ling Shiue
Journal:  Int J Nanomedicine       Date:  2021-02-05

2.  Caveolin-1 promotes tumor cell proliferation and vasculogenic mimicry formation in human glioma.

Authors:  Wenli Chen; Xing Cheng; Xiaobo Wang; Wenjie Hu; Jinshan Wang; Chuangxin Liao
Journal:  Braz J Med Biol Res       Date:  2021-07-16       Impact factor: 2.590

3.  Hypoxia-Induced Suppression of Antiapoptotic Bcl-2 Expression in Human Bladder Tumor Cells Is Regulated by Caveolin-1-Dependent Adenosine Monophosphate-Activated Protein Kinase Activity.

Authors:  Tae Jin Cho; Da-Hyun Lee; Bo-Hwa Choi; Helen K Shinn; Chang-Shin Park
Journal:  Int Neurourol J       Date:  2021-03-23       Impact factor: 2.835

4.  β-Patchoulene represses hypoxia-induced proliferation and epithelial-mesenchymal transition of liver cancer cells.

Authors:  Huahua Tu; Wei Wang; Yanqing Feng; Linfei Zhang; Huadong Zhou; Caitao Cheng; Lei Ji; Qinghe Cai; Yong Feng
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

5.  MiR-125b Loss Activated HIF1α/pAKT Loop, Leading to Transarterial Chemoembolization Resistance in Hepatocellular Carcinoma.

Authors:  Xiyang Wei; Lei Zhao; Ruizhe Ren; Fubo Ji; Shuting Xue; Jianjuan Zhang; Zhaogang Liu; Zhao Ma; Xin W Wang; Linda Wong; Niya Liu; Jiong Shi; Xing Guo; Stephanie Roessler; Xin Zheng; Junfang Ji
Journal:  Hepatology       Date:  2020-11-07       Impact factor: 17.298

Review 6.  Regulation of Endoplasmic Reticulum-Mitochondria Ca2+ Transfer and Its Importance for Anti-Cancer Therapies.

Authors:  Gaia Pedriali; Alessandro Rimessi; Luigi Sbano; Carlotta Giorgi; Mariusz R Wieckowski; Maurizio Previati; Paolo Pinton
Journal:  Front Oncol       Date:  2017-08-31       Impact factor: 6.244

7.  Caveolin-1 inhibits breast cancer stem cells via c-Myc-mediated metabolic reprogramming.

Authors:  Shengqi Wang; Neng Wang; Yifeng Zheng; Bowen Yang; Pengxi Liu; Fengxue Zhang; Min Li; Juxian Song; Xu Chang; Zhiyu Wang
Journal:  Cell Death Dis       Date:  2020-06-11       Impact factor: 8.469

8.  Lipoprotein (a): a promising prognostic biomarker in patients with hepatocellular carcinoma after curative resection.

Authors:  Xing-Hui Gao; Shuang-Shuang Zhang; Hao Chen; Kun Wang; Wen Xie; Fu-Bing Wang
Journal:  Onco Targets Ther       Date:  2018-09-17       Impact factor: 4.147

9.  Caveolin-1 enhances brain metastasis of non-small cell lung cancer, potentially in association with the epithelial-mesenchymal transition marker SNAIL.

Authors:  Yeong-Jin Kim; Ju-Hwi Kim; Ok Kim; Eun-Jung Ahn; Se-Jeong Oh; Md Rashedunnabi Akanda; In-Jae Oh; Shin Jung; Kyung-Keun Kim; Jae-Hyuk Lee; Hyung-Seok Kim; Hangun Kim; Kyung-Hwa Lee; Kyung-Sub Moon
Journal:  Cancer Cell Int       Date:  2019-06-28       Impact factor: 5.722

10.  Enhanced radiosensitizing by sodium glycididazole in a recurrent esophageal carcinoma tumor model.

Authors:  Peipei Wu; Jing Liu; Xiaorong Sun; Xiaolin Li; Ligang Xing; Jinming Yu
Journal:  Oncotarget       Date:  2017-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.